SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
85.20    1.20 (1.43%)
Bid:
85.20
Ask:
85.90
Spread: 0.70 (0.822%)
Market Cap: £238.73m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director Declaration

3 Jun 2019 12:21

RNS Number : 9579A
Essentra plc
03 June 2019
 

 

 

03 June 2019

 

 

Essentra plc

Appointment of Non-Executive Director & Remuneration Committee Chair Designate

 

 

 

Further to an announcement made on 01 March 2019, Essentra plc confirms the appointment of Nicki Demby as a Non-Executive Director & Remuneration Committee Chair Designate with effect from 01 June 2019.

 

In accordance with Listing Rule 9.6.13, there are no details to be disclosed.

 

As at the date of this announcement Nicki Demby does not own any ordinary shares in Essentra plc.

 

 

 

 

 

Enquiries:

 

Essentra plc

Jon Green

Company Secretary & General Counsel

T: 01908 359100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNCKNDDDBKDFAK
Date   Source Headline
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20238:19 amRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20238:49 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:02 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:05 amRNSStatement re Launch of Share Buyback Programme
29th Mar 20237:00 amRNSResults for the Full Year Ended 31 December 2022
21st Mar 20234:03 pmRNSStatement re 2022 Full Year Results Revised Date
2nd Mar 202310:20 amRNSNotice of Full Year 2022 Results
1st Mar 20239:19 amRNSTotal Voting Rights
21st Feb 20238:00 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSSpecial Dividend and Share Buyback Programme
1st Feb 20238:00 amRNSTotal Voting Rights
18th Jan 202312:06 pmRNSDirector Declaration
6th Jan 20237:00 amRNSFY22 Pre-Close Trading Update
3rd Jan 20237:10 amRNSTotal Voting Rights
3rd Jan 20237:00 amRNSDirectorate Change
20th Dec 202210:47 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSDirectorate Change
16th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSHolding(s) in Company
7th Dec 202212:00 pmRNSHolding(s) in Company
5th Dec 202210:31 amRNSCompletion of the sale of Filters business
5th Dec 20229:10 amRNSTotal Voting Rights
1st Dec 20228:00 amRNSHolding(s) in Company
1st Dec 20227:00 amRNSAcquisition of the Wixroyd Group
28th Nov 20227:00 amRNSHolding(s) in Company
17th Nov 20222:40 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSCapital Markets Event
10th Nov 202210:43 amRNSHolding(s) in Company
9th Nov 202212:49 pmRNSResult of General Meeting
7th Nov 20227:00 amRNSHolding(s) in Company
2nd Nov 20227:00 amRNSTotal Voting Rights
28th Oct 20222:36 pmRNSCapital Markets Event - date rescheduled
21st Oct 20222:48 pmRNSCirc re. Publication of Class 1 and Notice of GM
21st Oct 20227:00 amRNSQ3 2022 Trading Update
18th Oct 20224:04 pmRNSHolding(s) in Company
17th Oct 20228:32 amRNSHolding(s) in Company
10th Oct 202212:11 pmRNSDirector/PDMR Shareholding
6th Oct 202212:33 pmRNSDirector/PDMR Shareholding
6th Oct 202212:30 pmRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.